Unexplained weight loss (UWL), defined as a decrease in body weight of 5% or more within a six-month period without a clear cause, is a common yet challenging clinical scenario. It may be an indicator of underlying serious conditions, both malignant and non-malignant, warranting a comprehensive evaluation.
The initial approach to evaluating UWL should include a detailed history and physical examination. The history should focus on dietary intake, physical activity, changes in taste or smell, psychiatric symptoms, and other systemic symptoms. The physical examination should aim at identifying signs of chronic diseases, malignancies, or malnutrition.
Initial laboratory tests should include complete blood count, metabolic panel, thyroid function tests, and inflammatory markers. The role of imaging studies is not well-defined in the absence of specific symptoms or signs, but computed tomography (CT) of the abdomen and pelvis may be considered in certain cases.
Special populations may require additional investigations. In the elderly, cognitive impairment and social factors may contribute to UWL. In patients with HIV, UWL may be a sign of uncontrolled disease or opportunistic infections. In these cases, a tailored approach may be necessary.
Management should be directed at the underlying cause, if identified. In cases where no clear cause is found, symptomatic and nutritional support should be provided. A close follow-up is essential to monitor for new symptoms or signs that may point to a specific diagnosis.
Unexplained weight loss is a complex clinical issue that requires a systematic and comprehensive approach. While it can be a sign of serious underlying conditions, a thorough evaluation often leads to the identification of treatable causes. Continued research into this area is needed to further refine our approach and improve patient outcomes.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation